|
CHERP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.819300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.035100E-03 |
| Normal-vs-Stage2 |
3.201600E-01 |
| Normal-vs-Stage3 |
2.581400E-03 |
| Normal-vs-Stage4 |
6.093600E-02 |
| Stage1-vs-Stage2 |
1.976010E-01 |
| Stage1-vs-Stage3 |
3.573000E-01 |
| Stage1-vs-Stage4 |
7.376800E-01 |
| Stage2-vs-Stage3 |
9.130400E-02 |
| Stage2-vs-Stage4 |
4.685400E-01 |
| Stage3-vs-Stage4 |
3.690200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.656900E-03 |
| Normal-vs-AfricanAmerican |
4.218000E-01 |
| Normal-vs-Asian |
3.495000E-01 |
| Caucasian-vs-AfricanAmerican |
3.222200E-01 |
| Caucasian-vs-Asian |
9.262300E-02 |
| AfricanAmerican-vs-Asian |
8.381800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.046400E-02 |
| Normal-vs-Female |
3.101400E-03 |
| Male-vs-Female |
1.967440E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.799200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.179300E-03 |
| Normal-vs-Age(61-80Yrs) |
3.218300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.188810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.322400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.219400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.131200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.418400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.409000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.459600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.299460E-03 |
| Classical-VS-Follicular |
1.412170E-01 |
| Classical-VS-Other |
8.060400E-01 |
| Classical-VS-Normal |
5.489700E-02 |
| Tall-VS-Follicular |
5.166200E-02 |
| Tall-VS-Other |
1.811840E-01 |
| Tall-VS-Normal |
2.39649999999036E-05 |
| Follicular-VS-Other |
7.946800E-01 |
| Follicular-VS-Normal |
6.817000E-03 |
| Other-VS-Normal |
3.076800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.182100E-02 |
| Normal-vs-N1 |
7.826600E-04 |
| N0-vs-N1 |
1.070190E-01 |
|
|
